Medicine and Dentistry
Colorectal Carcinoma
100%
Neoplasm
59%
Lung Metastasis
43%
Immunocompetent Cell
43%
Metastatic Carcinoma
30%
Immunity
30%
Overall Survival
27%
CD3 Antigen
27%
Programmed Death-Ligand 1
26%
CD8 Antigen
21%
DNA Mismatch Repair
20%
Malignant Neoplasm
20%
T Cell
17%
Primary Tumor
17%
Immune Cell Infiltration
13%
Rectum Cancer
13%
Prognostic Factor
12%
Diseases
12%
Tumor Cell
11%
Immunotherapy
11%
Cellular Infiltration
10%
Comorbidity
10%
Survival Rate
10%
Liver Metastasis
9%
Colon Carcinoma
9%
T Lymphocyte
9%
Stroma
9%
Charlson Comorbidity Index
9%
Lymphocyte
9%
Cell Density
8%
Disease Specific Survival
8%
Adenocarcinoma
8%
Marker Gene
8%
DNA Methylation
8%
Arginase 1
8%
Ulcerative Colitis
8%
Rectum Resection
8%
Prostate Cancer
8%
Indoleamine 2,3 Dioxygenase
8%
Cytotoxic T-Cell
8%
Tertiary Lymphoid Structure
8%
Cholangiocarcinoma
8%
Macrophage
8%
Carcinogenesis
8%
Macrophage Polarization
8%
Myeloid Cell
8%
Hereditary Nonpolyposis Colorectal Cancer
8%
Thoracic Aorta
8%
Anastomosis Leakage
8%
Esophagectomy
8%
Keyphrases
Colorectal Cancer
58%
Pulmonary Metastasis
35%
Programmed Death-ligand 1 (PD-L1)
35%
Immune Cell Score
34%
Microsatellite Stable Colorectal Cancer
25%
Prognostic Value
20%
Primary Tumor
19%
Immune Environment
18%
Overall Survival
17%
Multiplex Analysis
16%
Population-based Study
16%
CD3+
15%
Colorectal Carcinoma
14%
Tumor
13%
Liver Metastasis
13%
Immunoprofiling
13%
Immune Infiltration
13%
Immune Contexture
13%
5-year Survival
12%
Lung Metastasis
11%
Prognostic Significance
11%
T Cells
11%
Independent Prognostic Factor
11%
Mismatch Repair
11%
Overall Survival Rate
11%
Improved Survival
10%
Spatial Analysis
10%
Multimodal Management
10%
Primary Colorectal Cancer
9%
CD8+
9%
PD-L1 Expression
9%
Tumor Budding
9%
Medical Records
9%
Comorbidity
9%
Charlson Comorbidity Index
9%
Hazard Ratio
8%
Tumor Cells
8%
Density Analysis
8%
Previous Treatment
8%
Oncological Outcomes
8%
Mutational Landscape
8%
Marker Genes
8%
Small Bowel Adenocarcinoma
8%
Colorectal Tumorigenesis
8%
Double-blinded Study
8%
Structured Electronic Medical Record
8%
Surgical Outcomes
8%
Acute Abdominal Pain
8%
Tumor-associated Macrophages
8%
Patients with Colorectal Cancer
8%
